October 19, 2016 |
The collaboration between IBM and Quest "is certainly interesting for the clinical sequencing market," wrote Evercore ISI analyst Ross Muken in a Tuesday note, pointing to the goal of bringing next-generation sequencing (NGS) to community oncologists.
TheStreet